Markets › India › NSE › BETA

Beta Drugs Ltd

NSE:BETAHealth Technology

₹1,719.60−3.56%At closeAt close · Mon 19 Oct · ≈ AED 66.44 · Market cap $207.95M · Next earnings Wed 28 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Gross margin	24.1%	28.2%	30.5%	28.5%	30.6%	27.9%	−2.7 pts
Operating margin	15.7%	19.4%	19.2%	17.0%	17.4%	15.5%	−1.9 pts
Net margin	10.2%	13.5%	13.5%	12.3%	11.7%	10.8%	−0.9 pts
EBITDA margin	21.7%	23.4%	23.8%	20.3%	20.9%	20.0%	−0.9 pts
Return on equity	17.1%	26.9%	25.0%	23.2%	21.5%	16.9%	−4.6 pts
Return on assets	10.0%	15.7%	15.5%	14.3%	9.7%	8.4%	−1.4 pts
Return on capital employed	21.7%	32.8%	32.2%	29.6%	18.9%	15.4%	−3.5 pts
Debt / equity	0.3×	0.2×	0.2×	0.1×	0.7×	0.6×	−12.1%
Debt / assets	14.9%	13.1%	10.2%	5.8%	31.6%	30.4%	−1.3 pts
Interest coverage	7.5×	18.8×	18.0×	17.8×	9.0×	3.9×	−56.8%
Current ratio	2.0×	2.0×	2.0×	2.1×	3.2×	3.1×	−3.8%
Quick ratio	1.5×	1.4×	1.5×	1.4×	2.6×	2.3×	−12.1%
Cash ratio	0.3×	0.4×	0.3×	0.3×	1.4×	1.2×	−19.3%
Asset turnover	1.0×	1.2×	1.1×	1.2×	0.8×	0.8×	−6.6%
Inventory turnover	4.7×	5.0×	4.4×	3.7×	3.9×	3.1×	−19.4%
Receivables turnover	3.0×	3.5×	3.2×	3.2×	3.1×	3.2×	+4.3%
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—